Commonwealth Medicine, Center for Health Policy and Research; Commonwealth Medicine, Clinical Pharmacy Services; Commonwealth Medicine, Office of Clinical Affairs/MassHealth
Health Economics | Health Policy | Health Services Administration | Health Services Research | Pharmaceutical Preparations | Pharmacoeconomics and Pharmaceutical Economics
This poster evaluates the financial impact of high-cost infused medications across three site of care programs. Site of care programs help payers save money on specialty drug spend by shifting utilization on high costs infused medications to less costly sites of administration. The objective of this project was to evaluate the costs associated with the administration of select high-cost infused medications in site of care programs in Massachusetts Medicaid populations. Research was done through retrospective analysis that included pharmacy and medical claims data for select high cost infused medications between April 1, 2017 - September 20, 2017.
This presentation was given at the 2018 Managed Care & Specialty Pharmacy Annual Meeting and received the AMCP Foundation Best Poster Award in the Resident and Fellows category.
Medicaid, Pharmacy, Drug Utilization Review
Rights and Permissions
© 2018 University of Massachusetts Medical School
DOI of Published Version
2018 Managed Care and Specialty Pharmacy Annual Meeting
Bagwell S, Lavitas P, Pomfret TC, Greenwood BC, Trask NM, Tran S, Schiff NL, Hydery T, Leto P, Price MK, Alper CJ, Lenz KJ, Jeffrey PL. (2018). A Comparison of the Costs Associated with the Administration of Select High-cost Infused Medications in Three Sites of Care for a State Medicaid Population. Commonwealth Medicine Publications. https://doi.org/10.13028/kx5p-ak35. Retrieved from https://escholarship.umassmed.edu/commed_pubs/189
Health Economics Commons, Health Policy Commons, Health Services Administration Commons, Health Services Research Commons, Pharmaceutical Preparations Commons, Pharmacoeconomics and Pharmaceutical Economics Commons